Literature DB >> 18850471

Personal costs of visual impairment by different eye diseases and severity of visual loss.

Elaine Y H Wong1, Shiao-Lan Chou, Ecosse L Lamoureux, Jill E Keeffe.   

Abstract

OBJECTIVES: To determine the personal out-of-pocket costs of visual impairment and to examine the expenditure pattern related to eye diseases and the severity of visual impairment.
METHODS: This prospective cohort study recruited participants of any age who were able to converse in English and had presenting visual acuity (VA) of < 6/12. Participants completed cost diaries regarding their daily personal vision-related expenditure. These were grouped under four categories: 1) medicines, products and equipment, 2) health and community services, 3) informal care and support and 4) other expenses. Socio-demographic and clinical data were also collected.
RESULTS: In 2003 150 participants, aged between 10 and 93 years old, were recruited. The median and mean total costs of visual impairment was Australian Dollars (AUD)$2416 and $3376, respectively (mode = AUD$2001-3000, SD +/- AUD$3050, Range AUD$7-$18610). Adjusting for age, there was no effect for severity of visual impairment (mild, moderate or severe) or type of eye diseases on the annual total personal out-of-pocket costs of visual impairment (p > 0.05).
CONCLUSIONS: Regardless of the type of eye diseases and the severity of visual loss, visual impairment posed a significant financial burden to both the individual and society.

Entities:  

Mesh:

Year:  2008        PMID: 18850471     DOI: 10.1080/09286580802227394

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

1.  [Methods for estimating personal costs of disease using retinal diseases as an example].

Authors:  G Porz; H P N Scholl; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

2.  The economic burden of visual impairment and blindness: a systematic review.

Authors:  Juliane Köberlein; Karolina Beifus; Corinna Schaffert; Robert P Finger
Journal:  BMJ Open       Date:  2013-11-07       Impact factor: 2.692

3.  Blindness and visual impairment in Central Europe.

Authors:  Marlene Glatz; Regina Riedl; Wilfried Glatz; Mona Schneider; Andreas Wedrich; Matthias Bolz; Rupert W Strauss
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

Review 4.  The economics of vision impairment and its leading causes: A systematic review.

Authors:  Ana Patricia Marques; Jacqueline Ramke; John Cairns; Thomas Butt; Justine H Zhang; Iain Jones; Marty Jovic; Allyala Nandakumar; Hannah Faal; Hugh Taylor; Andrew Bastawrous; Tasanee Braithwaite; Serge Resnikoff; Peng T Khaw; Rupert Bourne; Iris Gordon; Kevin Frick; Matthew J Burton
Journal:  EClinicalMedicine       Date:  2022-03-22

5.  Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.

Authors:  Nancy Cross; Cécile van Steen; Yasmina Zegaoui; Andrew Satherley; Luigi Angelillo
Journal:  Clin Ophthalmol       Date:  2022-06-20

6.  Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015.

Authors:  Seyed-Farzad Mohammadi; Cyrus Alinia; Ebrahim Ghaderi; Alireza Lashay; Mahmoud Jabbarvand; Elham Ashrafi; Naser Nourmohammadi; Saeid Shahraz
Journal:  Iran J Public Health       Date:  2019-07       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.